drugset / Trial / NCT02029599

The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis

NCT02029599 ↗

Phase 2 Completed 240 enrolled Maoxiang Group Jilin Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to evaluate the efficacy and safety of Fang yi qing Feng shi granules in subjects with Rheumatoid Arthritis.

Timeline

Start
2014-03
Primary completion
2015-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Fang yi qing feng shi granule Traditional medicine (herbal / TCM) 10 g Oral
Background Acetaminophen Small molecule 0.5 g Oral
Background Methotrexate Small molecule 7.5 mg Oral
Background Methotrexate Small molecule 15 mg Oral

Indications